DE10196213T1 - Verfahren erhöhter Bioverfügbarkeit von Nährstoffen und pharmazeutische Präparationen mit Tetrahydropiperin und Analoga und Derivaten davon - Google Patents

Verfahren erhöhter Bioverfügbarkeit von Nährstoffen und pharmazeutische Präparationen mit Tetrahydropiperin und Analoga und Derivaten davon

Info

Publication number
DE10196213T1
DE10196213T1 DE10196213T DE10196213T DE10196213T1 DE 10196213 T1 DE10196213 T1 DE 10196213T1 DE 10196213 T DE10196213 T DE 10196213T DE 10196213 T DE10196213 T DE 10196213T DE 10196213 T1 DE10196213 T1 DE 10196213T1
Authority
DE
Germany
Prior art keywords
tetrahydropiperine
analogues
nutrients
derivatives
pharmaceutical preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE10196213T
Other languages
German (de)
English (en)
Other versions
DE10196213B4 (de
Inventor
Muhammed Majeed
Vladimir Badmaev
Kumar Rajinder Bammi
Subbalakshmi Prakash
Sankaran Natarajan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sami Chemicals and Extracts Ltd
Sabinsa Corp
Original Assignee
Sami Chemicals and Extracts Ltd
Sabinsa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sami Chemicals and Extracts Ltd, Sabinsa Corp filed Critical Sami Chemicals and Extracts Ltd
Publication of DE10196213T1 publication Critical patent/DE10196213T1/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
DE10196213T 2000-05-19 2001-05-21 Verfahren erhöhter Bioverfügbarkeit von Nährstoffen und pharmazeutische Präparationen mit Tetrahydropiperin und Analoga und Derivaten davon Granted DE10196213T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20524500P 2000-05-19 2000-05-19
US27797901P 2001-03-23 2001-03-23
PCT/US2001/016070 WO2001089571A2 (en) 2000-05-19 2001-05-21 Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives

Publications (1)

Publication Number Publication Date
DE10196213T1 true DE10196213T1 (de) 2003-04-30

Family

ID=26900240

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10196213T Granted DE10196213T1 (de) 2000-05-19 2001-05-21 Verfahren erhöhter Bioverfügbarkeit von Nährstoffen und pharmazeutische Präparationen mit Tetrahydropiperin und Analoga und Derivaten davon
DE10196213.4A Expired - Lifetime DE10196213B4 (de) 2000-05-19 2001-05-21 Verwendung von Tetrahydropiperin zur Erhöhung der Bioverfügbarkeit von Nährstoffen und pharmazeutischen Präparationen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE10196213.4A Expired - Lifetime DE10196213B4 (de) 2000-05-19 2001-05-21 Verwendung von Tetrahydropiperin zur Erhöhung der Bioverfügbarkeit von Nährstoffen und pharmazeutischen Präparationen

Country Status (6)

Country Link
US (1) US6849645B2 (https=)
JP (1) JP4098985B2 (https=)
AU (1) AU2001278849A1 (https=)
DE (2) DE10196213T1 (https=)
GB (1) GB2380675B (https=)
WO (1) WO2001089571A2 (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005529123A (ja) * 2002-04-24 2005-09-29 リサーチ　ディベロップメント　ファンデーション 核転写調節因子ＮＦ−κＢ抑制剤と抗腫瘍薬の相乗効果
CA2489947A1 (en) * 2002-06-24 2003-12-31 Research Development Foundation Treatment of human multiple myeloma by curcumin
WO2004067018A1 (en) * 2003-01-30 2004-08-12 Council Of Scientific And Industrial Research Bioavailability enhancing activity of carum carvi extracts and fractions thereof
US7462646B2 (en) 2003-08-26 2008-12-09 Research Development Foundation Osteoclastogenesis inhibitors and uses thereof
US20050163873A1 (en) * 2004-01-14 2005-07-28 Robert Ritch Methods and formulations for treating glaucoma
JP5254616B2 (ja) 2004-09-13 2013-08-07 クロノ セラピューティクス、インコーポレイテッド 生物学的同調性（ｂｉｏｓｙｎｃｈｒｏｎｏｕｓ）経皮的薬物送達
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US20060130675A1 (en) * 2004-11-30 2006-06-22 Crawford David S Transdermal nutritional supplement delivery patch
US8372040B2 (en) 2005-05-24 2013-02-12 Chrono Therapeutics, Inc. Portable drug delivery device including a detachable and replaceable administration or dosing element
US20070237735A1 (en) * 2006-03-31 2007-10-11 Laboratoires Dermo-Cosmetik Inc. Anti-aging composition, kit and method of use
US20080138417A1 (en) * 2006-11-22 2008-06-12 Charles Grigsby Topical Composition And Method Of Forming
US20130017259A1 (en) 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 薬剤送達方法及びシステム
AU2016228779A1 (en) 2015-03-12 2017-09-07 Chrono Therapeutics Inc. Craving input and support system
WO2017020125A1 (en) * 2015-07-31 2017-02-09 Delivra Inc. Transdermal formulations for delivery of capsaicinoids
KR102655937B1 (ko) * 2016-09-27 2024-04-11 (주)아모레퍼시픽 코스모페린을 포함하는 항스트레스 조성물
WO2018069938A1 (en) * 2016-10-14 2018-04-19 Cipla Limited Pharmaceutical compositions comprising rifaximin
EP3565617A1 (en) 2017-01-06 2019-11-13 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
WO2019058386A1 (en) * 2017-09-19 2019-03-28 Cipla Limited COMPOSITIONS COMPRISING IBRUTINIB AND AN ALKALOID HAVING IMPROVED BIOAVAILABILITY
EP3801732A4 (en) 2018-05-29 2022-04-27 Morningside Venture Investments Limited METHODS AND SYSTEMS FOR DRUG DELIVERY
US12397141B2 (en) 2018-11-16 2025-08-26 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system
US20200179362A1 (en) * 2018-12-05 2020-06-11 James E. Beecham Dietary supplement comprising glucuronidation inhibition assist for healthful daily synergy of anti-inflammation, cellular anti-oxidant boost, cellular protein clean-up boost
JP7163261B2 (ja) * 2019-09-27 2022-10-31 富士フイルム株式会社 水中油型乳化組成物、及び皮膚外用剤
CN115670998A (zh) * 2022-11-18 2023-02-03 广州澳莱娜生物科技有限公司 一种祛痘控油亮肤组合物及其制备方法
CN115813822B (zh) * 2022-12-16 2024-06-25 厦门海尼新创生物科技有限公司 一种高效祛痘组合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984001264A1 (fr) * 1982-09-30 1984-04-12 Dainippon Jochugiku Kk Appareil de volatilisation thermique d'un agent medicinal
AU4382693A (en) * 1992-05-21 1993-12-13 Jeff J. Staggs Therapeutic uses of pungent botanicals and their related compounds
CA2098889A1 (en) * 1992-07-06 1994-01-07 Takashi Chinuki Slow-releasing medicated resin moldings and process for producing the same
EP0650728B1 (en) * 1993-10-29 2002-02-27 Council of Scientific and Industrial Research Pharmaceutical compositions containing piperine and an antituberculosis or antileprosydrug
IN176897B (https=) * 1993-10-29 1996-09-28 Cadila Lab Ltd
JP2946452B2 (ja) * 1994-11-04 1999-09-06 カディラ ラボラトリーズ リミテッド ピペリンを含む組成物
US5744161A (en) * 1995-02-24 1998-04-28 Sabinsa Corporation Use of piperine as a bioavailability enhancer
EP0935964A1 (en) * 1998-02-12 1999-08-18 Panacea Biotec Limited Pharmaceutical compositions containing NSAIDs and piperine
GB9815177D0 (en) * 1998-07-13 1998-09-09 King S College London Treatment of skin disorders

Also Published As

Publication number Publication date
US6849645B2 (en) 2005-02-01
JP4098985B2 (ja) 2008-06-11
WO2001089571A2 (en) 2001-11-29
JP2003534295A (ja) 2003-11-18
DE10196213B4 (de) 2020-12-17
GB0229561D0 (en) 2003-01-22
WO2001089571A3 (en) 2002-03-07
GB2380675B (en) 2004-11-03
GB2380675A (en) 2003-04-16
AU2001278849A1 (en) 2001-12-03
US20020058695A1 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
DE10196213T1 (de) Verfahren erhöhter Bioverfügbarkeit von Nährstoffen und pharmazeutische Präparationen mit Tetrahydropiperin und Analoga und Derivaten davon
EP1246608A4 (en) PHARMACEUTICAL FORMULATIONS FOR THE ADMINISTRATION OF MEDICAMENTS HAVING A LOW AQUEOUS SOLUBILITY
PT1032555E (pt) Aminoacidos ciclicos e derivados uteis como agentes farmaceuticos
ATE279193T1 (de) Pharmazeutische zubereitung von moxifloxacin
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
DE60121953D1 (de) Herstellungsverfahren von arzneizubereitungen
NO20022998L (no) Farmasöytiske preparater som tilveiebringer foröket konsentrasjon av medikament
DE60126321D1 (de) Gelsystem zur ocularen verabreichung von arzneimitteln
EP0731712A4 (en) PHYSIOLOGICALLY STABLE COMPOSITIONS OF BUTYRIC ACID, SALTS AND BUTYRIC ACID DERIVATIVES AS ANTINEOPLASTIC AGENTS
DE69812089D1 (de) Pharmazeutische omeprazol-formulierung
CY2013001I2 (el) Nεα παραγωγα κινουκλιδινης και ιατρικα σκευασματα που τα πepιεχουν
DE69325408D1 (de) Pharmazeutische Zubereitung in wässriger Suspensionsform
DE60201859D1 (de) Pharmazeutische Verwendung von N-Carbamoylazol-Derivate
ATE401908T1 (de) Pharmazeutische zusammensetzungen von erythropoietin
ATE383868T1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
NO982874D0 (no) Farmas°ytiske preparater med vitamin D-analoger
DE50213084D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
IS6723A (is) 10-arýl-11H-bensó[b]flúorenafleiður og hliðstæðurtil lyfjanotkunar
DE50006898D1 (de) Wässrige arzneimittelformulierung von moxifloxacin oder salzen davon
DE4495520T1 (de) Verfahren und pharmazeutische Zusammensetzung zum zielgerichten Anwenden von Wirkstoffen
EE04263B1 (et) Farmatseutiline kompositsioon piperidinoalkanoolantihistamiini ja selle derivaatide biosaadavuse suurendamiseks ning allergiliste reaktsioonide raviks patsiendil
DE69024843D1 (de) Rhodanin-Derivate und pharmazeutische Zusammensetzungen
DE69824582D1 (de) Chinolin- und naphthalincarboxamide, pharmazeutische zubereitungen und verfahren zur hemmung von calpain
DE50006823D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
ATE286906T1 (de) DIPHOSPHAT-SALZ VON EINEM 4ß-SUBSTITUTIERTE-9- DEOXO-9A-AZA-9A-HOMOERYTHROMYIN-DERIVAT UND SEINE PHARMAZEUTISCHE ZUBEREITUNG

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law

Ref document number: 10196213

Country of ref document: DE

Date of ref document: 20030430

Kind code of ref document: P

R071 Expiry of right
R020 Patent grant now final